Product Program year 2020 Source: CMS Open Payments

VIABAHN Endoprosthesis with Heparin Bioactive Surface

Device Devices

Open in the dashboard

General payments

$90,046

1,623 payments

Research payments

$0

0 payments

Through program year 2020, $90,046 in general payments and $0 in research payments were reported against VIABAHN Endoprosthesis with Heparin Bioactive Surface (Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $21,218 478
2019 General $68,828 1,145

Breakdown

Who paid General payments · program years 2019–2020
  1. W. L. Gore & Associates, Inc. $90,046 1,623 payments
Top recipients General payments · program year 2020
  1. Jacobo Nurko Vascular Surgery · Houston, TX $696 3% · 1 payment
  2. John Ross Vascular Surgery · Orangeburg, SC $569 3% · 5 payments
  3. Marcus Moseley Vascular Surgery · Owensboro, KY $486 2% · 2 payments
  4. Velupillai Wignakumar Surgery · Georgetown, KY $389 2% · 2 payments
  5. Robert Baldwin Thoracic Surgery (Cardiothoracic Vascular Surgery) · Houston, TX $361 2% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Vascular Surgery Surgery $12,340 58% · 162 practitioners
  2. Surgery $2,823 13% · 22 practitioners
  3. Vascular & Interventional Radiology Radiology $1,361 6% · 34 practitioners
  4. Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,081 5% · 16 practitioners
  5. Diagnostic Radiology Radiology $933 4% · 22 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Texas $3,021 14% · 39 recipients
  2. Florida $2,438 11% · 41 recipients
  3. California $1,623 8% · 18 recipients
  4. Michigan $1,490 7% · 10 recipients
  5. South Carolina $1,307 6% · 13 recipients

The top 5 of 43 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,623 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record